Tag: healthcare

Ergonomics and Human Factors practice are inherently broad and multi-disciplinary, but one thing that unites us all is a focus on design.

Important advancements within medical technology are opening up new possibilities for the healthcare industry to redefine itself through the use of devices able to provide, collect, analyse, and convey data.

Techniques such as AI and Machine Learning are creating new opportunities for healthcare and changing the way that people interact with health services.

This article explores the impact that environmental factors such as light have on healthcare and considers how they can be optimised to support patient and staff well-being.

Over recent years, PDD has conducted numerous observational and interview studies in China focusing on medical device design and nursing practice.

We are pleased to let you know that this autumn we will be present at some of the most prestigious medical events in China.

The PDD team was asked to produce a system that is both reliable and user-friendly and within a branding format that is suitable for a wide range of medical and industrial-commercial settings

Human Factors and Ergonomics contribute towards Digital Health by providing an understanding of the healthcare system, making sure we get the right tool for the job and making sure that the tool fits and fit for purpose.

Conducting any kind of patient-centric evaluation can present numerous challenges; preparing for and conducting evaluation sessions with patients suffering from sensitive and changeable conditions (such as Alzheimer’s) can present even more complex challenges, as we found out on a study we conducted in the past year.

Following our successful transition in June to the latest 2016 revision of ISO13485, we were certified in November for a further 3 years for our client services in research, design, engineering, pre-production manufacture, verification and validation.

PDD has completed its planned transition to the latest version of this rigorous international quality assurance standard for medical devices, building on the success of earlier transitions and successful audits to the FDA 21CFR Part 820 in 2015.

An extract taken from Chris Vincent’s knowledge piece that discusses the growing use of digital platforms such as social media to understand how people really use medical products.

The consumer goods sector (FMCG, apparel, automotive, electronics) has always had greater freedom to explore design research in comparison to the Pharma industry, which is significantly more restricted. One of the problems with a stricter and more constrained set of rules is that it can curb innovation by creating limitations in the approach Pharma companies take during the development process and justification for when Patient Centred Design comes into debate. Often regulatory walls can slow the development of a new products and services and directly affect the time taken to introduce a new product to market.

In my recent blog post on patient-centricity, I highlighted that the pharma industry has over the past years embarked on a journey towards more patient-centricity and that this trend actually has broad support across key players. At the same time, even with the best of intentions, it will take time for this new ethos to be truly embedded in the business practices of all pharma companies.

Last Thursday I got the opportunity to learn about the latest and greatest in VR and its applications in healthcare, courtesy of Health Tech Women. Over the course of 2 hours, the Virtual Reality Breakfast event in London showed how VR really is no longer just about video gaming and is being used to transform healthcare across a range of therapy areas.

In this first post of a three-part series, we look at the state of patient-centricity in the pharma industry today. In recent times, the pharma industry has increasingly adopted the mantra of“patient-centricity” which aims to put the patient at the heart of the company’s operation. The reality, however, still looks very different. Many are quick […]

All too often our health care is taken for granted, and we assume it will always be available to serve our community’s needs. The question is “How healthy are our healthcare facilities to handle the diversity of services and to produce healthy outcomes for an expansive and unprecedented market of six (6) living generations – all distinctively different with a diverse set of needs and priorities?”

Chris Vincent and I recently attended an AAMI training course held in Dublin on Human Factors for Medical devices. EU manufacturers and consultancies all attended with the hope of having some questions answered by the FDA.

Despite the many brands and models of drug infusion delivery devices available there are only a few different basic types of device. Considering the breadth of therapeutic application, physical infusion volumes and the economic context, the healthcare provider has a diminished choice and the patient (often the user) has barely any.

How do you measure usability? How do you really measure the efficiency of interface characteristics and user satisfaction in a way that can feed opportunities to develop and innovate? As a usability consultant, it is not that uncommon to be asked to evaluate usability. Some would even go so far as to say it comes with the territory.